WO2007092380A3 - Apolipoprotein e genotyping and accompanying internet-based health management system - Google Patents

Apolipoprotein e genotyping and accompanying internet-based health management system Download PDF

Info

Publication number
WO2007092380A3
WO2007092380A3 PCT/US2007/003034 US2007003034W WO2007092380A3 WO 2007092380 A3 WO2007092380 A3 WO 2007092380A3 US 2007003034 W US2007003034 W US 2007003034W WO 2007092380 A3 WO2007092380 A3 WO 2007092380A3
Authority
WO
WIPO (PCT)
Prior art keywords
apolipoprotein
genotyping
management system
health management
patient
Prior art date
Application number
PCT/US2007/003034
Other languages
French (fr)
Other versions
WO2007092380A2 (en
Inventor
Matthew Banet
Randon Schultz
Marshal Dhillon
Adam Fleming
Henk Visser
Christopher Hall
Vance Lanier Jr
Original Assignee
Berkeley Heartlab Inc
Matthew Banet
Randon Schultz
Marshal Dhillon
Adam Fleming
Henk Visser
Christopher Hall
Vance Lanier Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berkeley Heartlab Inc, Matthew Banet, Randon Schultz, Marshal Dhillon, Adam Fleming, Henk Visser, Christopher Hall, Vance Lanier Jr filed Critical Berkeley Heartlab Inc
Publication of WO2007092380A2 publication Critical patent/WO2007092380A2/en
Publication of WO2007092380A3 publication Critical patent/WO2007092380A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Abstract

The invention provides a system for monitoring a patient that includes: 1) a blood test that measures an Apo E genotype or a derivative thereof from the patient to generate Apo E information; 2) a database that receives and stores the patient's Apo E information; and 3) an Internet-based system connected to the database and configured to process the Apo E information with an algorithm that, in response, generates a diet and treatment plan for the patient.
PCT/US2007/003034 2006-02-06 2007-02-06 Apolipoprotein e genotyping and accompanying internet-based health management system WO2007092380A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77113806P 2006-02-06 2006-02-06
US60/771,138 2006-02-06

Publications (2)

Publication Number Publication Date
WO2007092380A2 WO2007092380A2 (en) 2007-08-16
WO2007092380A3 true WO2007092380A3 (en) 2007-11-01

Family

ID=38230306

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/003034 WO2007092380A2 (en) 2006-02-06 2007-02-06 Apolipoprotein e genotyping and accompanying internet-based health management system

Country Status (1)

Country Link
WO (1) WO2007092380A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090150134A1 (en) * 2007-11-13 2009-06-11 Entelos, Inc. Simulating Patient-Specific Outcomes

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004349A2 (en) * 1999-07-09 2001-01-18 Institut Pasteur De Lille Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
US6251587B1 (en) * 1997-12-16 2001-06-26 Nova Molecular, Inc. Method for determining the prognosis of a patient with a neurological disease
WO2001079234A2 (en) * 2000-04-14 2001-10-25 Genaissance Pharmaceuticals, Inc. Haplotypes of the apoe gene
WO2002064735A2 (en) * 2001-02-12 2002-08-22 Akzo Nobel N.V. Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4
EP1434053A1 (en) * 2001-10-04 2004-06-30 Immuno-Biological Laboratories Co., Ltd. Reagent for detecting risk factor for alzheimer's disease, detection kit therefor and method of detecting risk factor for alzheimer's disease using the same
US20050009193A1 (en) * 2003-05-27 2005-01-13 Berkeley Heartlab, Inc. Method for selecting an optimal diet and exercise regimen based on a LDL and HDL subclass determination
US20050261594A1 (en) * 2004-01-06 2005-11-24 Triage Wireless, Inc. Vital signs monitor used for conditioning a patient's response

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251587B1 (en) * 1997-12-16 2001-06-26 Nova Molecular, Inc. Method for determining the prognosis of a patient with a neurological disease
WO2001004349A2 (en) * 1999-07-09 2001-01-18 Institut Pasteur De Lille Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
WO2001079234A2 (en) * 2000-04-14 2001-10-25 Genaissance Pharmaceuticals, Inc. Haplotypes of the apoe gene
WO2002064735A2 (en) * 2001-02-12 2002-08-22 Akzo Nobel N.V. Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4
EP1434053A1 (en) * 2001-10-04 2004-06-30 Immuno-Biological Laboratories Co., Ltd. Reagent for detecting risk factor for alzheimer's disease, detection kit therefor and method of detecting risk factor for alzheimer's disease using the same
US20050009193A1 (en) * 2003-05-27 2005-01-13 Berkeley Heartlab, Inc. Method for selecting an optimal diet and exercise regimen based on a LDL and HDL subclass determination
US20050261594A1 (en) * 2004-01-06 2005-11-24 Triage Wireless, Inc. Vital signs monitor used for conditioning a patient's response

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BAI J. ET AL.: "Design and Development of an Interactive Medical Teleconsultation System over the World Wide Web", IEEE TRANSACTIONS ON INFORMATION TECHNOLOGY IN BIOMEDICINE, IEEE SERVICE CENTER, LOS ALAMITOS, CA, US, vol. 2, no. 2, June 1998 (1998-06-01), XP011028302, ISSN: 1089-7771 *
DESPRES JEAN-PIERRE ET AL: "HDL-cholesterol as a marker of coronary heart disease risk: The Quebec cardiovascular study", ATHEROSCLEROSIS, vol. 153, no. 2, December 2000 (2000-12-01), pages 263 - 272, XP002446810, ISSN: 0021-9150 *
NAUCK M. ET AL.: "Evaluation of the Apo E Genotyping Kit on the Light-Cycler", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, US, vol. 46, 2000, pages 722 - 724, XP002259654, ISSN: 0009-9147 *
PIRA R.S. ET AL.: "Supporting asynchronous telemedicine: multimedia mail vs. the World Wide Web vs. replicated databases", CANADIAN CONFERENCE ON ELECTRICAL AND COMPUTER ENGINEERING - CONGRES CANADIEN EN GENIE ELECTRIQUE ET INFORMATIQUE, XX, XX, vol. 1, 24 May 1998 (1998-05-24), pages 341 - 344, XP002139926 *
STAN SIMONA ET AL: "Distribution of LDL particle size in a population-based sample of children and adolescents and relationship with other cardiovascular risk factors", CLINICAL CHEMISTRY, vol. 51, no. 7, July 2005 (2005-07-01), pages 1192 - 1200, XP002446809, ISSN: 0009-9147 *
UCHIDA Y. ET AL.: "SANDWICH ELISA FOR THE MEASUREMENT OF APO-E4 LEVELS IN SERUM AND THE ESTIMATION OF THE ALLELIC STATUS OF EPO-E4 ISOFORMS", JOURNAL OF CLINICAL LABORATORY ANALYSIS, NEW YORK, NY, US, vol. 14, no. 6, 2000, pages 260 - 264, XP008023599, ISSN: 0887-8013 *

Also Published As

Publication number Publication date
WO2007092380A2 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
WO2007121170A3 (en) Physiological signal processing devices and associated processing methods
WO2007014147A3 (en) Method and system for monitoring medical treatment
GB2457000A (en) System and method for in-situ mental health monitoring and therapy administration
WO2007040963A3 (en) Internet-based system for monitoring blood test, vital sign, and exercise information from a patient
WO2011139345A3 (en) Pathway recognition algorithm using data integration on genomic models (paradigm)
WO2007024555A3 (en) Electronic personal health record system
WO2006122325A3 (en) Methods and systems for monitoring and enhancing patient compliance with a health treatment program
WO2007143083A3 (en) A system and methods for chronic disease management and health assessment
WO2007005622A3 (en) System and method for assessing individual healthfulness and for providing health-enhancing behavioral advice and promoting adherence thereto
ATE492208T1 (en) DEVICE FOR MEASURING A PATIENT'S IMMEDIATE PERCEPTIONAL VALUES
WO2006084195A3 (en) Personal assessment including familial risk analysis for personalized disease prevention plan
RU2010142176A (en) METHODS AND SYSTEMS FOR CREATING FODDER COMPOSITIONS
WO2006076653A3 (en) Database system for centralized clinical and research applications with data from wavefront aberrometers
WO2007112397A3 (en) System and method of predicting efficacy of tongue-base therapies
WO2007070767A3 (en) External user interface based measurement association
WO2007014307A3 (en) System and method for health care data integration and management
GB2478065A (en) Method and systems for personalized action plans
WO2007079146A8 (en) Treatment for non-hodgkin's lymphoma
WO2006002211A3 (en) System and method for assisting a care partner in monitoring a patient with chronic disease
WO2007079171A3 (en) Treatment for hodgkin's lymphoma
WO2006119349A3 (en) Choroid and retinal imaging and treatment system
BRPI0715118B8 (en) therapy prescription system and apparatus
WO2005119590A3 (en) Method and apparatus for health control
WO2007149319A8 (en) System and method for collecting patient information from which diabetes therapy may be determined
WO2009132328A3 (en) Medical device tracking system with tray and method

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07763189

Country of ref document: EP

Kind code of ref document: A2